Cargando…
Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury
Adeno-associated viral (AAV) vectors are a promising system for transgene delivery into the central nervous system (CNS) based on their safety profile and long-term gene expression. Gene delivery to the CNS has largely been neuron centric but advances in AAV technology are facilitating the developme...
Autores principales: | Griffin, Jarred M., Fackelmeier, Barbara, Fong, Dahna M., Mouravlev, Alexander, Young, Deborah, O’Carroll, Simon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760677/ https://www.ncbi.nlm.nih.gov/pubmed/30962538 http://dx.doi.org/10.1038/s41434-019-0075-6 |
Ejemplares similares
-
Transcriptional activity of novel ALDH1L1 promoters in the rat brain following AAV vector-mediated gene transfer
por: Mudannayake, Janitha M, et al.
Publicado: (2016) -
GFAP expression in injured astrocytes in rats
por: Zhang, Shuquan, et al.
Publicado: (2017) -
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013) -
Beyond the GFAP-Astrocyte Protein Markers in the Brain
por: Jurga, Agnieszka M., et al.
Publicado: (2021) -
Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy
por: van Ballegoij, Wouter J. C., et al.
Publicado: (2020)